Reuters logo
3 years ago
Boston Scientific adjusted profit rises due to higher device sales
April 29, 2014 / 11:20 AM / 3 years ago

Boston Scientific adjusted profit rises due to higher device sales

1 Min Read

April 29 (Reuters) - Boston Scientific Corp reported a higher adjusted profit in the first quarter, helped by higher sales of its neuromodulation and heart rhythm management devices.

The company's net earnings rose to $133 million, or 10 cents per share, in the quarter ended March 31, compared with a loss of $354 million, or 26 cents per share, a year earlier when it took goodwill impairment, resutructuring and other charges of$578 million.

Excluding items, earnings rose to $268 million, or 20 cents per share, from $224 million, or 16 cents per share, from a year earlier. (Reporting by Vrinda Manocha in Bangalore; Editing by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below